Viral infection induces the activation of the innate immune and Type I interferon responses, which act to restrict viral replication and spread. West Nile virus (WNV) is an emerging mosquito-borne pathogen that can cause fatal encephalitis in multiple vertebrate animal species. In the majority of cases, activation of the cell-intrinsic and cell-extrinsic innate immune responses controls viral replication and prevents encephalitis and death. Understanding the mechanisms by which WNV infection is inhibited by the innate immune response requires an understanding of the antiviral functions of innate immune proteins induced by infection. In this proposal, we will characterize the antiviral action of an evolutionarly conserved family of proteins termed interferon-induced protein with tetratricopeptide repeats (IFIT). IFIT proteins are induced early and to high levels during an innate immune response and have been shown to recognize viral RNA as non-self due to the presence of atypical RNA modifications at the 5' end; however, the mechanism by which this recognition occurs and the role of individual IFIT proteins in recognizing viral RNA has yet to be determined. Here, we will use biochemical and cell-culture based assays to determine the ability of IFIT proteins to bind viral RNA and determine how RNA binding and recognition inhibits viral replication. We also will use a mouse model lacking all three Ifit genes to assess tissue- and cell-type-specific effects of IFIT antiviral activity. We hypothesize that different combinations of IFIT proteins will differentially affect viral replication and that IFIT proteins will show a tissue- and cell type-specific dominance. The results of this study may support the use of viruses from multiple families that are highly susceptible to IFIT antiviral activity as novel vaccines and provide an avenue for development of novel antiviral agents that sensitize viruses to the antiviral effects of IFIT proteins.

Public Health Relevance

These studies will define the mechanisms of antiviral action by interferon induced tetratricopeptide repeat (IFIT) proteins, a highly evolutionarily conserved family of innate immune effector proteins involved in the suppression of a variety of viral infections. Understanding these mechanisms may provide support for the development of novel vaccines and antiviral treatments against many virus families.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AI112274-02
Application #
9014416
Study Section
Special Emphasis Panel (ZRG1-F13-C (20))
Program Officer
Repik, Patricia M
Project Start
2015-01-01
Project End
2016-12-31
Budget Start
2016-01-01
Budget End
2016-12-31
Support Year
2
Fiscal Year
2016
Total Cost
$57,962
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
White, James P; Xiong, Shanshan; Malvin, Nicole P et al. (2018) Intestinal Dysmotility Syndromes following Systemic Infection by Flaviviruses. Cell 175:1198-1212.e12
Daniels, Brian P; Jujjavarapu, Harsha; Durrant, Douglas M et al. (2017) Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection. J Clin Invest 127:843-856
Pinto, Amelia K; Williams, Graham D; Szretter, Kristy J et al. (2015) Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae Families. J Virol 89:9465-76
Reynaud, Josephine M; Kim, Dal Young; Atasheva, Svetlana et al. (2015) IFIT1 Differentially Interferes with Translation and Replication of Alphavirus Genomes and Promotes Induction of Type I Interferon. PLoS Pathog 11:e1004863